Data from TCGA showed that, compared to normal adjacent tissue, breast cancers had a significantly increased expression of YBEY. However, metastatic disease (i.e., Stage IV) had significantly decreased YBEY expression compared with Stage I and II breast cancers. This evidence concerns the gene YBEY and breast carcinoma.